Compound Evidence File
#EC-2026-0381
PNC 27
Filed under Peptides. The bureau holds 51 laboratory returns for this compound from 16 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
16 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 9.2 | 8.1 | 10.0 | 25 May 2026 | 25 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.9 | 7.5 | 10.0 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.5 | 7.2 | 9.5 | 21 May 2026 | 21 May 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 8.1 | 8.1 | 8.1 | 28 Mar 2025 | 28 Mar 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 8.1 | 8.1 | 8.1 | 9 Jun 2025 | 9 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 7.9 | 6.5 | 10.0 | 21 May 2026 | 21 May 2026 |
| LSPLCASE #VI-2026-0523 | X | 3 | 7.5 | 7.0 | 7.9 | 25 Apr 2025 | 24 May 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 7.2 | 7.2 | 7.2 | 8 Jul 2025 | 8 Jul 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 7.2 | 7.2 | 7.2 | 7 May 2025 | 7 May 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 7.2 | 7.2 | 7.2 | 7 May 2025 | 7 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 6.8 | 6.5 | 7.2 | 23 May 2026 | 23 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 5.6 | 5.6 | 5.6 | 3 Jul 2025 | 3 Jul 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 2.9 | 2.9 | 2.9 | 24 Apr 2025 | 24 Apr 2025 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 0.0 | 0.0 | 0.0 | 17 Dec 2024 | 17 Dec 2024 |
Open any subject to view the batch-level evidence for PNC 27 alone.